Dr. Breelyn Wilky, M.D.
Claim this profileUniversity of Colorado
Studies Soft Tissue Sarcoma
Studies Cancer
17 reported clinical trials
28 drugs studied
About Breelyn Wilky, M.D.
Education:
- Received M.D. from the University of Chicago Pritzker School of Medicine in 2006.
Experience:
- Currently an Assistant Professor of Medical Oncology at the University of Colorado School of Medicine, focusing on sarcoma and gastrointestinal cancers.
- Formerly an Assistant Professor at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine.
- Research interests include novel therapies for sarcomas and gastrointestinal stromal tumors (GISTs), along with clinical trials for these conditions.
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
HLA-A positive
2Cancer
Stage IV
Stage III
FGFR positive
Affiliated Hospitals
Clinical Trials Breelyn Wilky, M.D. is currently running
ADI-PEG 20 + Chemotherapy
for Leiomyosarcoma
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
Recruiting1 award Phase 310 criteria
Doxorubicin + Dual Checkpoint Blockade
for Soft Tissue Sarcoma
This trial tests a combination of chemotherapy and immune-boosting drugs in cancer patients. The goal is to see if this combination works better than chemotherapy alone by helping the body's natural defenses fight cancer more effectively. Combination therapies of chemotherapy and immunotherapy have shown promising results in initial studies, with potential synergistic effects enhancing anti-tumor immunity.
Recruiting1 award Phase 215 criteria
More about Breelyn Wilky, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Breelyn Wilky, M.D. has experience with
- Placebo
- Cabozantinib
- Nivolumab
- Doxorubicin
- AGEN1884 And AGEN2034
- Ipilimumab
Breakdown of trials Breelyn Wilky, M.D. has run
Soft Tissue Sarcoma
Cancer
Uterine Leiomyosarcoma
Bone Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Breelyn Wilky, M.D. specialize in?
Breelyn Wilky, M.D. focuses on Soft Tissue Sarcoma and Cancer. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Breelyn Wilky, M.D. currently recruiting for clinical trials?
Yes, Breelyn Wilky, M.D. is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Breelyn Wilky, M.D. has studied deeply?
Yes, Breelyn Wilky, M.D. has studied treatments such as Placebo, Cabozantinib, Nivolumab.
What is the best way to schedule an appointment with Breelyn Wilky, M.D.?
Apply for one of the trials that Breelyn Wilky, M.D. is conducting.
What is the office address of Breelyn Wilky, M.D.?
The office of Breelyn Wilky, M.D. is located at: University of Colorado, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.